Search
Clascoterone
go.drugbank.com/drugs/DB12499ApprovedInvestigational[A218846] In August 2020, FDA approved clascoterone for the first-in-class topical treatment of acne (acne vulgaris) in male and female patients 12 years and older. … proliferation, excess sebum production, and inflammatory pathways.
Categories: Hormones, Hormone Substitutes, and Hormone AntagonistsUblituximab
go.drugbank.com/drugs/DB11850ApprovedInvestigational[A241045] In December 2022, ublituximab was approved by the US FDA for the treatment of relapsing forms of multiple sclerosis, becoming the first and only anti-CD20 monoclonal antibody for multiple sclerosis … CD20, an antigen expressed by various B and T cells, is an attractive therapeutic target in various cancers and autoimmune conditions.
Categories: Amino Acids, Peptides, and Proteins, Antineoplastic and Immunomodulating AgentsInflammatory Muscle Disease
go.drugbank.com/conditions/DBCOND0155571Synonyms: Other inflammatory and immune myopathies, not elsewhere classifiedRivastigmine
go.drugbank.com/drugs/DB00989ApprovedInvestigationalRivastigmine is a cholinesterase inhibitor that inhibits both butyrylcholinesterase and acetylcholinesterase.
Products: Exelon Oral Solution 2mg/mlMannitol
go.drugbank.com/drugs/DB00742ApprovedInvestigationalMannitol elevates blood plasma osmolality, resulting in enhanced flow of water from tissues, including the brain and cerebrospinal fluid, into interstitial fluid and plasma. … On October 30, 2020, mannitol was approved by the FDA as add-on maintenance therapy for the control of pulmonary symptoms associated with cystic fibrosis in adult patients and is currently marketed for
Mixtures: INFUSOL M20S (Mannitol 17.5%w/v and Sorbitol 2.5%w/v Intravenous Infusion), TERUFLEX Blood Bag System Anticoagulant Citrate Phosphate Dextrose (CPD) AND OPTISOL Red Cell PreservativeCategories: Diet, Food, and Nutrition, Alimentary Tract and MetabolismEthchlorvynol
go.drugbank.com/drugs/DB00189ApprovedIllicitWithdrawnEthchlorvynol is a sedative and hypnotic drug. It has been used to treat insomnia, but has been largely superseded and is only offered where an intolerance or allergy to other drugs exists.
Categories: Hypnotics and SedativesEtuvetidigene Autotemcel
go.drugbank.com/drugs/DB17593ApprovedInvestigational[L54698] First approved by the FDA on December 9, 2025, etuvetidigene autotemcel is used to treat Wiskott–Aldrich syndrome (WAS) in selected pediatric and adult patients. … [A274878] The WAS protein is expressed on non-erythroid hematopoietic cells and regulates the function of actin filaments in the cytoskeleton.[A274878]
Fredrickson Type III lipidemia
go.drugbank.com/conditions/DBCOND0106234Drugs: AtorvastatinSynonyms: Familial hyperbetalipoproteinemia and hyperprebetalipoproteinemia, Familial hyperbetalipoproteinaemia and hyperprebetalipoproteinaemiaLower Respiratory Tract Infections
go.drugbank.com/conditions/DBCOND0052142Synonyms: Lower Respiratory Tract and Lung Infections, Lower respiratory tract and lung infectionRespiratory Tract Diseases
go.drugbank.com/conditions/DBCOND0029282Synonyms: Respiratory, thoracic, and mediastinal disorders, Respiratory, thoracic and mediastinal disorders